Tissue-specificmRNA deliveryand prime editing withpeptideionizable lipid nanoparticles The development of peptide codes for organ-selective mRNA delivery represents a significant advancement in therapeutic biotechnology. This innovative approach utilizes specific peptide sequences to guide messenger RNA (mRNA) payloads to targeted organs within the body, overcoming previous limitations in precise delivery. The ultimate goal is to unlock the full therapeutic potential of mRNA-based technologies, enabling more effective gene and protein replacement therapies.
At the forefront of this field is the peptide-encoded organ-selective targeting (POST) methodLiving Machines Laboratory. This strategy involves programming lipid nanoparticles (LNPs) with short peptide sequences. These "POST" peptides act as molecular addresses, directing the LNPs carrying mRNA to specific organs beyond the liver, which has been a common site for systemic mRNA delivery. By engineering these peptide codes, researchers can achieve a higher degree of control over where the therapeutic mRNA exerts its effects, thereby enhancing efficacy and minimizing off-target interactions.
The ability to achieve organ-selective mRNA delivery is crucial for a wide range of potential applications. Historically, delivering mRNA payloads precisely to tissues outside the liver has been a significant challenge2025年9月1日—Here we report apeptide-encoded organ-selective targeting (POST) methodfor the delivery of mRNA to extrahepatic organs after systemic .... The introduction of peptide-encoded organ-selective targeting addresses this by leveraging the inherent targeting capabilities of peptides. These short amino acid sequences can be designed to bind to specific receptors or markers present on the surface of target cells in particular organs. When incorporated into LNPs, these peptides facilitate the enhanced uptake of the mRNA cargo by the intended cellular machinery.
The POST method, and similar peptide-modified strategies, allow for the programming of LNP delivery systems. This means that not only the payload (mRNA) but also its destination can be precisely controlledThe resulting peptide-modified lipids exhibit the capacity for targeted delivery to various organs and realize gene editing function.. This level of precision is vital for applications such as gene editing, protein replacement, and the development of novel vaccines. For instance, tissue-specific mRNA delivery could enable localized treatment of genetic disorders affecting organs like the lungs, heart, or brain, which have been difficult to reach with conventional delivery methods. The ongoing research into peptide-modified lipids for organ-specific mRNA delivery further expands the toolkit for achieving these targeted therapeutic outcomes.
While the development of peptide codes for organ-selective mRNA delivery shows immense promise, challenges remain期刊论文Peptide codes for organ-selective mRNA delivery复制. 用户6X7Ch8WUQ_gI 2个月前 77 10 已完结. 1. 系统已在2025-10-25 09:03:13对应助文件进行删除. 2.. Optimizing peptide sequences for maximum targeting efficiency and minimal immunogenicity is an ongoing area of researchOrgan-selective delivery of messenger RNA (mRNA) iscritical for fulfilling the therapeutic potentialof mRNA-based gene and protein replacement .... Furthermore, scaling up the production of these peptide-modified LNPs for clinical use will require robust manufacturing processesOrgan-selective deliveryof messenger RNA (mRNA) is critical for fulfilling the therapeutic potential ofmRNA-based gene and protein replacement technologies.. Nevertheless, the progress made in this area suggests a future where mRNA therapeutics can be delivered with unprecedented precision, heralding a new era of personalized and effective medicine.
Join the newsletter to receive news, updates, new products and freebies in your inbox.